Endometrial Adenocarcinoma in a 27-Year-Old Woman
Background Endometrial adenocarcinoma usually occurs after menopause, but in 2%–14% of cases, it occurs in young patients (less than 40 years of age) who are eager to preserve their fertility. Its treatment includes hysterectomy, bilateral salpingo-oophorectomy and pelvic lymphadenectomy, and, in so...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2010-01-01
|
Series: | Clinical Medicine Insights: Case Reports |
Online Access: | https://doi.org/10.4137/CCRep.S5346 |
id |
doaj-1417e3461cba4f27ab928f1fa38d9660 |
---|---|
record_format |
Article |
spelling |
doaj-1417e3461cba4f27ab928f1fa38d96602020-11-25T03:19:23ZengSAGE PublishingClinical Medicine Insights: Case Reports1179-54762010-01-01310.4137/CCRep.S5346Endometrial Adenocarcinoma in a 27-Year-Old WomanAnis Fadhlaoui0Jamel Ben Hassouna1Mohamed Khrouf2Fethi Zhioua3Anis Chaker4Medical University of Tunis, 15 Rue Djebel Lakhdhar, Bab Saadoun 1007, Tunis, Tunisia.Medical University of Tunis, 15 Rue Djebel Lakhdhar, Bab Saadoun 1007, Tunis, Tunisia.Medical University of Tunis, 15 Rue Djebel Lakhdhar, Bab Saadoun 1007, Tunis, Tunisia.Medical University of Tunis, 15 Rue Djebel Lakhdhar, Bab Saadoun 1007, Tunis, Tunisia.Medical University of Tunis, 15 Rue Djebel Lakhdhar, Bab Saadoun 1007, Tunis, Tunisia.Background Endometrial adenocarcinoma usually occurs after menopause, but in 2%–14% of cases, it occurs in young patients (less than 40 years of age) who are eager to preserve their fertility. Its treatment includes hysterectomy, bilateral salpingo-oophorectomy and pelvic lymphadenectomy, and, in some cases, radiation therapy. Aim To describe a case of endometrial adenocarcinoma occurring in a young woman and to undertake a literature review of risk factors and therapeutic options proposed for young women wishing to preserve their fertility. Case We report a case of endometrial cancer in a 27-year-old woman treated for resistant menorrhagia and cared for in our department as well as in the Salah Azaiez Institute. Conclusion Endometrial adenocarcinoma rarely occurs in young women. In such cases, other therapeutic options can be proposed: progesterone therapy and LH-RH (Luteinzing-Hormone-Releasing-Hormone) agonists therapy in order to preserve fertility in younger patients.https://doi.org/10.4137/CCRep.S5346 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Anis Fadhlaoui Jamel Ben Hassouna Mohamed Khrouf Fethi Zhioua Anis Chaker |
spellingShingle |
Anis Fadhlaoui Jamel Ben Hassouna Mohamed Khrouf Fethi Zhioua Anis Chaker Endometrial Adenocarcinoma in a 27-Year-Old Woman Clinical Medicine Insights: Case Reports |
author_facet |
Anis Fadhlaoui Jamel Ben Hassouna Mohamed Khrouf Fethi Zhioua Anis Chaker |
author_sort |
Anis Fadhlaoui |
title |
Endometrial Adenocarcinoma in a 27-Year-Old Woman |
title_short |
Endometrial Adenocarcinoma in a 27-Year-Old Woman |
title_full |
Endometrial Adenocarcinoma in a 27-Year-Old Woman |
title_fullStr |
Endometrial Adenocarcinoma in a 27-Year-Old Woman |
title_full_unstemmed |
Endometrial Adenocarcinoma in a 27-Year-Old Woman |
title_sort |
endometrial adenocarcinoma in a 27-year-old woman |
publisher |
SAGE Publishing |
series |
Clinical Medicine Insights: Case Reports |
issn |
1179-5476 |
publishDate |
2010-01-01 |
description |
Background Endometrial adenocarcinoma usually occurs after menopause, but in 2%–14% of cases, it occurs in young patients (less than 40 years of age) who are eager to preserve their fertility. Its treatment includes hysterectomy, bilateral salpingo-oophorectomy and pelvic lymphadenectomy, and, in some cases, radiation therapy. Aim To describe a case of endometrial adenocarcinoma occurring in a young woman and to undertake a literature review of risk factors and therapeutic options proposed for young women wishing to preserve their fertility. Case We report a case of endometrial cancer in a 27-year-old woman treated for resistant menorrhagia and cared for in our department as well as in the Salah Azaiez Institute. Conclusion Endometrial adenocarcinoma rarely occurs in young women. In such cases, other therapeutic options can be proposed: progesterone therapy and LH-RH (Luteinzing-Hormone-Releasing-Hormone) agonists therapy in order to preserve fertility in younger patients. |
url |
https://doi.org/10.4137/CCRep.S5346 |
work_keys_str_mv |
AT anisfadhlaoui endometrialadenocarcinomaina27yearoldwoman AT jamelbenhassouna endometrialadenocarcinomaina27yearoldwoman AT mohamedkhrouf endometrialadenocarcinomaina27yearoldwoman AT fethizhioua endometrialadenocarcinomaina27yearoldwoman AT anischaker endometrialadenocarcinomaina27yearoldwoman |
_version_ |
1724622778936590336 |